ADAMTS13 and thrombotic thrombocytopenic purpura: Indeed, the inactivity or severe deficiency of ADAMTS13 is the pivotal laboratory parameter enabling to distinguish TTP from other thrombotic microangiopathies, especially from hemolytic–uremic syndrome (HUS) [7].